[1] [1] JOSHI S S, BADGWELL B D. Current treatment and recent progress in gastric cancer[J]. CA Cancer J Clin, 2021, 71(3): 264-279.

[2] [2] TALEBI M, VATANMAKANIAN M, MIRZAEI A, et al. Platelet-rich and platelet-poor plasma might play supportive roles in cancer cell culture: a replacement for fetal bovine serum?[J]. Anticancer Agents Med Chem, 2021, 21(16): 2236-2242.

[3] [3] MUSSANO F, GENOVA T, MUNARON L, et al. Cytokine, chemokine, and growth factor profile of platelet-rich plasma[J]. Platelets, 2016, 27(5): 467-471.

[4] [4] URZ O, OLOFSSON BAGGE R, CRESCITELLI R. The dark side of foetal bovine serum in extracellular vesicle studies[J]. J Extracell Vesicles, 2022, 11(10): e12271.

[6] [6] ANITUA E, ZALDUENDO M, TROYA M, et al. Platelet-rich plasma as an alternative to xenogeneic sera in cell-based therapies: a need for standardization[J]. Int J Mol Sci, 2022, 23(12): 6552.

[7] [7] BERNDT S, TURZI A, PITTET-CUNOD B, et al. Autologous platelet-rich plasma (CuteCell PRP) safely boostsin vitrohuman fibroblast expansion[J]. Tissue Eng Part A, 2019, 25(21-22): 1550-1563.

[8] [8] XIAN L J, CHOWDHURY S R, BIN SAIM A, et al. Concentration-dependent effect of platelet-rich plasma on keratinocyte and fibroblast wound healing[J]. Cytotherapy, 2015, 17(3): 293-300.

[9] [9] AMABLE P R, TEIXEIRA M V T, CARIAS R B V, et al. Mesenchymal stromal cell proliferation, gene expression and protein production in human platelet-rich plasma-supplemented media[J]. PLoS One, 2014, 9(8): e104662.

[10] [10] DO AMARAL R J, MATSIKO A, TOMAZETTE M R, et al. Platelet-rich plasma releasate differently stimulates cellular commitment toward the chondrogenic lineage according to concentration[J]. J Tissue Eng, 2015, 6: 204173141559 4127.

[11] [11] BECCIA E, CARBONE A, CECCHINO L R, et al. Adipose stem cells and platelet-rich plasma induce vascular-like structures in a dermal regeneration template[J]. Tissue Eng Part A, 2021, 27(9-10): 631-641.

[12] [12] KISHIMOTO S, ISHIHARA M, MORI Y, et al. Effective expansion of human adipose-derived stromal cells and bone marrow-derived mesenchymal stem cells cultured on a fragmin/protamine nanoparticles-coated substratum with human platelet-rich plasma[J]. J Tissue Eng Regen Med, 2013, 7(12): 955-964.

[13] [13] GUIOTTO M, RIEHLE M O, RAFFOUL W, et al. Is human platelet lysate (hPL) the ideal candidate to substitute the foetal bovine serum for cell-therapy translational research?[J]. J Transl Med, 2021, 19(1): 426.

[14] [14] JOHNSON C D L, ZALE N E, FRARY E D, et al. Feeder-cell-free and serum-free expansion of natural killer cells using cloudz microspheres, G-Rex6M, and human platelet lysate[J]. Front Immunol, 2022, 13: 803380.

[15] [15] DUARTE ROJAS J M, RESTREPO MNERA L M, ESTRADA MIRA S. Comparison between platelet lysate, platelet lysate serum, and fetal bovine serum as supplements for cell culture, expansion, and cryopreservation[J]. Biomedicines, 2024, 12(1): 140.

[16] [16] SOVKOVA V, VOCETKOVA K, RAMPICHOVA M, et al. Platelet lysate as a serum replacement for skin cell culture on biomimetic PCL nanofibers[J]. Platelets, 2018, 29(4): 395-405.